Aleksandra Niedzwiecki
Aleksandra
Niedzwiecki is werkzaam in het team van onderzoekers dat samenwerkt met Dr Rath en heeft
baanbrekend onderzoek op haar naam staan. Ik kon geen informatie in Nederland vinden over
haar werk dus helaas alleen Engelse info.
Ron
Aleksandra
Niedzwiecki, Ph.D.
Executive
Vice President and Director of Research, Dr. Niedzwiecki has been instrumental in
the development and growth of Cellular Medicine research. Dr. Niedzwiecki is a leading
biomedical researcher in the development of nutritional therapies for the treatment of
diseases. She has a doctorate degree in biochemistry from the University of Warsaw,
Poland. Dr. Niedzwiecki has held research faculty positions at Rockefeller University in
New York, the University of Toronto, and the University of Warsaw.
She is the former director
of cardiovascular research at the prestigious Linus Pauling Institute, formerly located in
California. Dr. Niedzwiecki has conducted groundbreaking research in the molecular biology
of aging, cellular metabolism, and cardiovascular disease. She has directly worked with
the Nobel Laureates Linus Pauling and G.M. Edelman. Dr. Niedzwiecki has been an invited
speaker at numerous conferences and scientific meetings, and she has published over 70
scientific publications in respected professional journals, written chapters in books, and
authored several popular research articles. For the last 13 years, Dr. Niedzwiecki has
been a close associate of Dr. Rath in conducting Cellular Medicine research. She is a
Fellow of the American College of Nutrition and a member of the American Heart
Association, the American Medical Women’s Association and other professional
organizations.
The Dr. Rath Research Institute applauded
the findings of Dr. Mark Levine and colleagues at the U.S. National Institutes of Health,
which show that vitamin C has the potential to fight cancer when used in high dosages. The
study confirms earlier research findings published in numerous scientific cancer journals
by scientists from the Dr. Rath Research Institute.
The institute's research documents that
vitamin C, when used in combination with the amino acids L-lysine and L-proline and a
polyphenol fraction of green tea known as Epigallocatechin Gallate (EGCG), could not only
kill cancer cells, but limit tumor growth, its infiltration by blood vessels
(angiogenesis), and completely stop the invasion and spread of more than two dozen cancer
cell types. While the NIH study showed a 50 percent decrease in survival of cancer cells
exposed to high doses of vitamin C in five out of nine cancer cell types, the combination
of nutrients used by Rath's group was effective not only in eliminating cancer cells, but
in arresting cancer cell tissue invasion -- a hallmark of metastasis responsible for 90
percent of deaths from cancer. Today, there are no effective measures to stop cancer
metastasis.
Dr. Matthias Rath, founder of the Dr.
Rath Research Institute, said, "The use of lysine, an amino acid, in combination with
ascorbic vitamin C addresses common pathomechanisms of cancer, will lead to a breakthrough
in the control of many forms of cancer and other diseases." Dr. Rath first published
his concept of the natural control of cancer in the Journal of Applied Nutrition in 1992.
Research that confirmed Dr. Rath's
approach was publicized in an advertisement in USA Today on March 8, 2002. Further
research was presented at the 19th Annual Miami Breast Cancer Conference in February of
2002; at the American Association of Cancer Research Special Conference in Cancer Research
in South Carolina in October of 2002; at many other national and international
conferences; and in many publications. The most recent findings can be found at the Breast
Cancer Research Web site at http://breast-cancer-research.com/content/7/3/R291.
"By using nutrient synergy and
defining correct biological targets, we could achieve superior physiological effects,
which is not possible with a single nutrient therapy, even if applied at extreme
doses," said Dr. Aleksandra Niedzwiecki, director of research at the institute.
The Dr. Rath Research Institute is
calling for a radical change in the treatment of cancer, one that takes advantage of new
natural approaches. Conventional approaches, such as chemotherapy and radiation, have been
unsuccessful in reducing the high mortality rate of the disease, have contributed only to
the accelerated cost of health care, and led to the development of new diseases that
result from the side effects of these treatments.
The Dr. Rath Research Institute offers
innovative, safe, effective, and natural solutions to cancer. To learn more, visit www.drrathresearch.org.
Source: Dr. Rath Education
Services USA, BV
Tumors in rats by
combination of lysine, proline,
arginine, ascorbic acid and green tea extract
M Waheed Roomi, Nusrath W
Roomi, Vadim Ivanov, Tatiana Kalinovsky, Aleksandra Niedzwiecki, M. Rath
The results of the present
study showed that the specificnutrient mixture of lysine, proline, arginine, ascorbic
acid,and green tea extract tested significantly inhibited the inci-dence, as well as the
growth, of MNU-induced mammarytumors. Although clinical trials are necessary to assess
theantitumor ability of the tested nutrient mixture on cancerpatients, the results of this
study suggest strong potentialfor its use as a therapeutic regimen for inhibiting
breastcancer development
Full report
New Research Indicates Essential
Nutrients Can Inhibit the Spread of Deadly Pancreatic Cancer
Innovative research conducted by
scientists under the direction of Aleksandra Niedzwiecki, Ph.D. at the Dr. Rath Research
Institute indicates that the spread of pancreatic cancer can be inhibited with a specific
nutrient combination. The research findings, published in the latest issue of the
International Journal of Gastrointestinal Cancer (2005, Volume 35:2; 97-102), further
validate Dr. Matthias Rath's novel approach to controlling cancer metastasis with
essential nutrients.
There is no cure for pancreatic cancer,
which has the poorest prognosis among cancer malignancies. Conventional approaches,
including surgery, chemotherapy and radiation, have been unsuccessful reducing the high
mortality rate of this disease. Dr. Rath's research team incubated the human pancreatic
cell line MIA PaCa-2 with a nutrient mixture composed of vitamin C, lysine, other amino
acids and green tea to observe its effects in inhibiting the proliferation and invasion of
this deadly form of cancer.
This research direction was inspired by
Dr. Rath's work who, in 1992, postulated that vitamin C and lysine could act as natural
inhibitors of the degradation of connective tissue, a common pathomechanism in all types
of malignancies. The study results corroborated earlier research with different types of
cancer and showed that the nutrient mixture exerted a significant anti-proliferative
effect and completely inhibited the invasion of pancreatic cancer cells. These nutrients
also reduced the secretion of matrix metalloproteinases (MMPs), the enzymes that cancer
cells use to degrade the surrounding connective tissue and spread in the body.
"Our research proves that specific
nutrients can control pancreatic and other forms of cancer because they target the four
characteristics of the disease -- proliferation, invasion, new blood vessel formation and
cell survival," Dr. Niedzwiecki said. "This new data calls for a critical
revision of current approaches to cancer and a focus on the development of natural, safe
and effective means of controlling this devastating illness."
The Dr. Rath Research Institute has been
leading the way in this new approach to cancer research based on the Cellular Medicine
concept, which has consistently proven the powerful therapeutic effect of synergistically
acting nutrients in controlling cancer development and spread. Research Institute
scientists have presented the results of their work at numerous scientific conferences and
published them in peer-reviewed scientific journals.
The Dr. Rath Research Institute offers
innovative, safe and effective natural solutions to cancer. To learn more, visit www.drrathresearch.org.
